These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24913707)

  • 1. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
    Jiang H; Zhao W; Shao W
    Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
    Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
    Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
    Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.
    Zhao L; Gu C; Huang K; Zhang Z; Ye M; Fan W; Han W; Meng Y
    Arch Gynecol Obstet; 2016 Nov; 294(5):1019-1029. PubMed ID: 27300001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant expression of CD44 in preneoplastic lesions of the lung.
    Wimmel A; Kogan E; Ramaswamy A; Schuermann M
    Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
    Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
    J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
    Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
    Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-C in non-small cell lung cancer: meta-analysis.
    Jiang H; Shao W; Zhao W
    Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma.
    Situ D; Long H; Lin P; Zhu Z; Wang J; Zhang X; Xie Z; Rong T
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1213-9. PubMed ID: 20127360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD44s expression in biliary tract cancers.
    Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN
    Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
    Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
    Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.